{"id":43695,"date":"2012-04-25T11:13:00","date_gmt":"2012-04-25T11:13:00","guid":{"rendered":"http:\/\/euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/pathway-genomics-adds-prominent-bioinformatics-experts-to-scientific-advisory-board.php"},"modified":"2012-04-25T11:13:00","modified_gmt":"2012-04-25T11:13:00","slug":"pathway-genomics-adds-prominent-bioinformatics-experts-to-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/pathway-genomics-adds-prominent-bioinformatics-experts-to-scientific-advisory-board.php","title":{"rendered":"Pathway Genomics Adds Prominent Bioinformatics Experts to Scientific Advisory Board"},"content":{"rendered":"<p><p>    SAN DIEGO--(BUSINESS WIRE)--  <\/p>\n<p>        Pathway Genomics Corporation, a genetic testing laboratory    specializing in     nutrition and exercise response,     inherited disease,     prescription drug response and     health condition risks, has established a world-leading        scientific advisory board. Among the board members are    James Fowler, Ph.D., professor of medical genetics at UCSD    School of Medicine, Christoph Lange, Ph.D., associate professor    of biostatistics at Harvard University School of Public Health,    and Nicholas Schork, Ph.D., director of bioinformatics and    biostatistics at the Scripps Translational Science Institute.  <\/p>\n<p>    Additionally, the companys internal computational and    bioinformatics team is led by Lixin Zhou, Ph.D., former senior    scientist at Illumina and former collaborative bioinformatics    investigator at The Institute for Genomic Research, an    organization of The J. Craig Venter Institute.  <\/p>\n<p>    Working with innovators in specific and technical fields helps    Pathway bring highly accurate, useful and actionable    information to physicians and their patients, said Michael    Nova, M.D., Pathway Genomics chief medical officer. Were    committed to seeking out this actionable genetic information    through computational biology methods, and cloud-based    bioinformatics.  <\/p>\n<p>    An acclaimed behavioral geneticist, James Fowler, Ph.D., is    currently a professor of medical genetics at UCSD School of    Medicine, and is world-renowned for his breakthrough    discoveries in genetics and social networking, behavioral    economics, cooperation, and political behavior.  <\/p>\n<p>    Christoph Lange, Ph.D., is an assistant professor of medicine    at Harvard Medical School and an associate professor of    biostatistics at Harvard School of Public Health. Langes    current research interests fall into the broad areas of    statistical genetics and generalized linear models.  <\/p>\n<p>    Nicholas J. Schork, Ph.D., is a professor at The Scripps    Research Institute in the department of molecular and    experimental medicine and director of bioinformatics and    biostatistics at the Scripps Translational Science Institute.    Schorks research focuses are in quantitative human genetics    and integrated approaches to complex biological and medical    problems. He has published over 350 scientific articles and    book chapters analyzing complex, multifactorial traits and    diseases.  <\/p>\n<p>    Pathways scientific advisory board consists of 10 leaders in    various fields including behavioral genetics, bioinformatics,    biostatistics, endocrinology, human epigenetics, metabolism,    nutrigenomics, nutrition, obesity and exercise genetics,    oncology, and weight management. To view the companys full    scientific advisory board, visit     <a href=\"http:\/\/www.pathway.com\/sab\" rel=\"nofollow\">http:\/\/www.pathway.com\/sab<\/a>.  <\/p>\n<p>    About Pathway Genomics  <\/p>\n<p>    Pathway Genomics owns and operates an on-site     genetic testing laboratory that is accredited by the    College of American Pathologists (CAP), accredited in    accordance with the U.S. Health and Human Services Clinical    Laboratory Improvement Amendments (CLIA) of 1988, and licensed    by the state of California. Using only a saliva sample, the    company incorporates customized and scientifically validated    technologies to generate personalized reports, which address a    variety of medical issues, including an individuals carrier    status for recessive genetic conditions, food metabolism and    exercise response, prescription drug response, and propensity    to develop certain diseases such as heart disease, type 2    diabetes and cancer. For more information about Pathway    Genomics, visit     <a href=\"http:\/\/www.pathway.com\" rel=\"nofollow\">http:\/\/www.pathway.com<\/a>.  <\/p>\n<\/p>\n<p>Go here to see the original: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/pathway-genomics-adds-prominent-bioinformatics-150000140.html;_ylt=A2KJjagx3JdP5GQAVDz_wgt.\" title=\"Pathway Genomics Adds Prominent Bioinformatics Experts to Scientific Advisory Board\">Pathway Genomics Adds Prominent Bioinformatics Experts to Scientific Advisory Board<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> SAN DIEGO--(BUSINESS WIRE)-- Pathway Genomics Corporation, a genetic testing laboratory specializing in nutrition and exercise response, inherited disease, prescription drug response and health condition risks, has established a world-leading scientific advisory board. Among the board members are James Fowler, Ph.D., professor of medical genetics at UCSD School of Medicine, Christoph Lange, Ph.D., associate professor of biostatistics at Harvard University School of Public Health, and Nicholas Schork, Ph.D., director of bioinformatics and biostatistics at the Scripps Translational Science Institute. Additionally, the companys internal computational and bioinformatics team is led by Lixin Zhou, Ph.D., former senior scientist at Illumina and former collaborative bioinformatics investigator at The Institute for Genomic Research, an organization of The J <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/pathway-genomics-adds-prominent-bioinformatics-experts-to-scientific-advisory-board.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-43695","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/43695"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=43695"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/43695\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=43695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=43695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=43695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}